Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Mallinckrodt
Covington
Cipla
UBS
Baxter
QuintilesIMS
Healthtrust
Harvard Business School

Generated: May 27, 2018

DrugPatentWatch Database Preview

DALGAN Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Dalgan, and when can generic versions of Dalgan launch?

Dalgan is a drug marketed by Astrazeneca and is included in one NDA.

The generic ingredient in DALGAN is dezocine. There is one drug master file entry for this compound. Additional details are available on the dezocine profile page.
Summary for DALGAN
Drug patent expirations by year for DALGAN
Synonyms for DALGAN
(-)-13beta-Amino-5,6,7,8,9,10,11alpha,12-octahydro-5alpha-methyl-5,11-methanobenzocyclodecen-3-ol
(-5alpha, 11alpha,13s)-13-amino-5,6,7,8,9,10,11,12-octahydro-5-methyl-5,11-methanobenzocyclodecen-3-ol
(1R,9S,15S)-15-amino-1-methyltricyclo[7.5.1.0;{2,7}]pentadeca-2,4,6-trien-4-ol
(5R,11S,13S)-13-amino-5-methyl-5,6,7,8,9,10,11,12-octahydro-5,11-methanobenzo[10]annulen-3-ol
(5R,11S,13S)-13-amino-5-methyl-5,6,7,8,9,10,11,12-octahydro-5,11-methanobenzocyclodecen-3-ol
13-Amino-5,6,7,8,9,10,11,12-octahydro-5-methyl-5,11-methanobenzocyclodecenol
15-AMINO-1-METHYLTRICYCLO[7.5.1.0(2),?]PENTADECA-2(7),3,5-TRIEN-4-OL
5,11-Methanobenzocyclodecen-3-ol, 13-amino-5,6,7,8,9,10,11,12-octahydro-5-methyl-, (5alpha,11alpha,13S*)-, (-)-
53648-55-8
648D558
AC1L24L4
AC1MHV5E
AC1NDSKX
AJ-45764
AK129761
AKOS016014025
AN-5609
API0002287
BDBM50276568
C08010
CHEBI:4474
CHEMBL1685
D00838
D0P6VV
Dalgan (TN)
DB01209
Dezocina
Dezocina [INN-Spanish]
DEZOCINE
Dezocine (USAN)
Dezocine [USAN:INN]
Dezocine hydrobromide
Dezocinum
Dezocinum [INN-Latin]
DTXSID2022911
FT-0687298
L000770
LS-90701
NCGC00274273-01
PL004212
SCHEMBL12720257
SCHEMBL1369581
SCHEMBL3072
SCHEMBL7781933
UNII-VHX8K5SV4X
VHX8K5SV4X
WY 16,225
WY 16225
Wy-16,225
Wy-16225

US Patents and Regulatory Information for DALGAN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Astrazeneca DALGAN dezocine INJECTABLE;INJECTION 019082-001 Dec 29, 1989 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Astrazeneca DALGAN dezocine INJECTABLE;INJECTION 019082-002 Dec 29, 1989 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Astrazeneca DALGAN dezocine INJECTABLE;INJECTION 019082-003 Dec 29, 1989 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for DALGAN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Astrazeneca DALGAN dezocine INJECTABLE;INJECTION 019082-003 Dec 29, 1989 ➤ Try a Free Trial ➤ Try a Free Trial
Astrazeneca DALGAN dezocine INJECTABLE;INJECTION 019082-001 Dec 29, 1989 ➤ Try a Free Trial ➤ Try a Free Trial
Astrazeneca DALGAN dezocine INJECTABLE;INJECTION 019082-002 Dec 29, 1989 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Teva
Argus Health
Covington
Chubb
QuintilesIMS
Fuji
Colorcon
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.